The effects of chronic copper exposure on the amyloid protein metabolisim associated genes' expression in chronic cerebral hypoperfused rats

Neuroscience Letters

Volumn 518, Issue 1, 2012, Pages 14-18

  Mao, Xuexuan ^a   Ye, Jiantao ^a   Zhou, Shiyou ^b   Pi, Rongbiao ^a   Dou, Juan ^a,c   Zang, Linquan ^d   Chen, Xiaohong ^a   Chao, Xiaojuan ^a   Li, Wenming ^c   Liu, Mengfei ^a   Liu, Peiqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Guangdong College of Pharmaceutical Sciences   (China)

Author keywords

Alzheimer's disease; Amyloid protein; Cerebral hypoperfusion; Copper

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; COPPER; MESSENGER RNA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CEREBRAL HYPOPERFUSION; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE EXACERBATION; GENE EXPRESSION; GENETIC ASSOCIATION; MALE; MAZE TEST; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; RAT;

AMYLOID; ANIMALS; BRAIN; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COPPER; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MAZE LEARNING; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84861531493     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.04.030     Document Type: Article

References (37)

1. Adlard P.A., Bush A.I. Metals and Alzheimer's disease. Journal of Alzheimer's Disease 2006, 10:145-163.
2. Bayer T.A., Schäfer S., Simons A., Kemmling A., Kamer T., Tepest R., Eckert A., Schüssel K., Eikenberg O., Sturchler-Pierrat C., Abramowski D., Staufenbiel M., Multhaup G. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:14187-14192.
3. Barnham K.J., McKinstry W.J., Multhaup G., Galatis D., Morton C.J., Curtain C.C., Williamson N.A., White A.R., Hinds M.G., Norton R.S., Beyreuther K., Masters C.L., Parker M.W., Cappai R. Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. Journal of Biological Chemistry 2003, 278:17401-17407.
4. Cater M.A., McInnes K.T., Li Q.X., Volitakis I., La Fontaine S., Mercer J.F., Bush A.I. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms. Biochemical Journal 2008, 412:141-152.
5. Crouch P.J., Hung L.W., Adlard P.A., Cortes M., Lal V., Filiz G., Perez K.A., Nurjono M., Caragounis A., Du T., Laughton K., Volitakis I., Bush A.I., Li Q.X., Masters C.L., Cappai R., Cherny R.A., Donnelly P.S., White A.R., Barnham K.J. Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:381-386.
6. Cao X., Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001, 293:115-120.
7. Farkas E., Luiten P.G., Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Research Reviews 2007, 54:162-180.
8. Hardy J., Cullen K. Amyloid at the blood vessel wall. Nature Medicine 2006, 12:756-757.
9. He X., Zhang Z., Zhang H., Zhao Y., Chai Z. Neurotoxicological evaluation of long-term lanthanum chloride exposure in rats. Toxicological Sciences 2008, 103:354-361.
10. Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Tanzi R.E., Bush A.I. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. Journal of Biological Inorganic Chemistry 2004, 9:954-960.
11. Huang X., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J.D., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., Scarpa R.C., Saunders A.J., Lim J., Moir R.D., Glabe C., Bowden E.F., Masters C.L., Fairlie D.P., Tanzi R.E., Bush A.I. Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. Journal of Biological Chemistry 1999, 274:37111-37116.
12. Humpel C. Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?. Experimental Gerontology 2011, 46:225-232.
13. Hung Y.H., Bush A.I., Cherny R.A. Copper in the brain and Alzheimer's disease. Journal of Biological Inorganic Chemistry 2010, 15:61-76.
14. Kitazawa M., Cheng D., LaFerla F.M. Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. Journal of Neurochemistry 2009, 108:1550-1560.
15. Koike M.A., Garcia F.G., Kitazawa M., Green K.N., Laferla F.M. Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia. Neuroscience Letters 2011, 495:55-59.
16. Leiva J., Palestini M., Infante C., Goldschmidt A., Motles E. Copper suppresses hippocampus LTP in the rat, but does not alter learning or memory in the morris water maze. Brain Research 2009, 1256:69-75.
17. Lin R., Chen X., Li W., Han Y., Liu P., Pi R. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin. Neuroscience Letters 2008, 440:344-347.
18. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. Journal of the Neurological Sciences 1998, 158:47-52.
19. Lu J., Wu D.M., Zheng Y.L., Sun D.X., Hu B., Shan Q., Zhang Z.F., Fan S.H. Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway. Brain, Behavior, and Immunity 2009, 23:193-203.
20. Marlatt M.W., Lucassen P.J., Perry G., Smith M.A., Zhu X. Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. Journal of Alzheimer's Disease 2008, 15:199-210.
21. Marx J., Neuroscience Possible role for environmental copper in Alzheimer's disease. Science 2003, 301:905.
22. Migliore L., Coppede F., Genetics environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutation Research 2009, 667:82-97.
23. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Schneider J.A., Wilson R.S., Scherr P.A. Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Archives of Neurology 2006, 63:1085-1088.
24. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 1996, 271:1406-1409.
25. Ozcelik D., Uzun H. Copper intoxication; antioxidant defenses and oxidative damage in rat brain. Biological Trace Element Research 2009, 127:45-52.
26. Pluta R., Ulamek M., Jablonski M. Consideration of the ischaemic basis and treatment of Alzheimer's disease. Folia Neuropathologica 2010, 48:11-26.
27. Railey A.M., Groeber C.M., Flinn J.M. The effect of metals on spatial memory in a transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease 2011, 24:375-381.
28. Rocchi A., Orsucci D., Tognoni G., Ceravolo R., Siciliano G. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects. Current Alzheimer's Research 2009, 6:224-237.
29. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron 2001, 32:177-180.
30. Schäfer S., Pajonk F.G., Multhaup G., Bayer T.A. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels. Journal of Molecular Medicine (Berlin) 2007, 85:405-413.
31. Shang Y.Z., Miao H., Cheng J.J., Qi J.M. Effects of amelioration of total flavonoids from stems and leaves of Scutellaria baicalensis Georgi on cognitive deficits, neuronal damage and free radicals disorder induced by cerebral ischemia in rats. Biological and Pharmaceutical Bulletin 2006, 29:805-810.
32. Squitti R., Lupoi D., Pasqualetti P., Dal Forno G., Vernieri F., Chiovenda P., Rossi L., Cortesi M., Cassetta E., Rossini P.M. Elevation of serum copper levels in Alzheimer's disease. Neurology 2002, 59:1153-1161.
33. Tanzi R.E., Moir R.D., Wagner S.L. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 2004, 43:605-608.
34. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 286:735-741.
35. Ye J.T., Pi R.B., Mao X.X., Chen X.H., Qin J., Xu S.W., Liu P.Q. Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain. Neuroreport 2009, 20:1456-1460.
36. Youdim M.B.H., Mandel S., Amit T., Bar-Am O. Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents. Progress in Neurobiology 2007, 82:348-360.
37. Zhang J., Mori A., Chen Q., Zhao B. Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Neuroscience 2006, 143:63-72.